Stanford Industry Interactions Policy
Message from Dean Philip Pizzo:
Video length: 4:37 min
As many of you know, we implemented the Stanford Industry Interactions Policy (SIIP) in October 2006. This policy governs interactions, largely in the clinical and educational arenas, with the pharmaceutical, biotech, medical device, and hospital and research equipment and supplies industries. (Research interactions are governed by a separate policy.) It includes provisions regarding, among other issues, gifts from industry, access of sales and marketing representatives to our campus, and industry support of education.
Since the initial promulgation of SIIP, relationships with industry have come under ever increasing national scrutiny, and the importance of policies like SIIP has become even more evident. Stanford School of Medicine, in conjunction with Stanford Hospital & Clinics (SHC) and Lucile Packard Children's Hospital (LPCH), was among the first institutions in the nation to embrace such policies. The actions we took are now rapidly becoming the standard of practice across the nation.
We are now updating our umbrella policy to include, among other changes, our CME Commercial Support Policy, which was introduced in 2008. The updated version also provides greater clarity concerning participation in meetings or conferences supported by industry and makes explicit, among other things, that participation by Stanford faculty in so-called speakers bureaus is contrary to the policy.
SIIP continues to be the defining document for our interactions with industry in the clinical care and educational areas. Given the prominence of these issues in the public domain and the changing landscape of conflict of interest, it is important that we maintain the currency of the policy and that all of us assure that our own interactions with industry comply with its provisions. Thank you for your continuing attention to this important area.
Sincerely,
Philip Pizzo, MD
May 2009
